Trial Profile
A study of extended-release naltrexone to investigate changes in striatal dopamine transporter availability and symptoms of depression and anhedonia in heroin-dependent patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2016
Price :
$35
*
At a glance
- Drugs Naltrexone (Primary)
- Indications Opioid-related disorders
- Focus Adverse reactions; Therapeutic Use
- 11 Feb 2016 New trial record